Research Articles | Page 17 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
MDS with 5q deletion and rare cKIT positive mastocytosis: a diagnostic and therapeutic challenge Apr 2019 BMJ Case Reports Myelodysplastic Syndromes (MDS)
Management of myelodysplastic syndromes after failure of response to hypomethylating agents May 2019 Therapeutic Advances in Hematology Myelodysplastic Syndromes (MDS)
Management of higher risk myelodysplastic syndromes after hypomethylating agents failure: are we about to exit the black hole? Sep 2020 Expert Review of Hematology Myelodysplastic Syndromes (MDS)
Management of aplastic anemia after failure of frontline immunosuppression Jul 2019 Expert Review of Hematology Aplastic Anemia
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes Sep 2020 Blood Myelodysplastic Syndromes (MDS)
Luspatercept use for lower risk myelodysplastic syndromes: Active but not enough Jun 2023 American Journal of Hematology Myelodysplastic Syndromes (MDS)
Luspatercept in the treatment of lower-risk myelodysplastic syndromes Jan 2021 Future Oncology (London, England) Myelodysplastic Syndromes (MDS)
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes Jan 2020 The New England Journal of Medicine Myelodysplastic Syndromes (MDS)
Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies Mar 2024 Expert Opinion on Biological Therapy Myelodysplastic Syndromes (MDS)
Lowering the boom on lower-risk myelodysplastic syndromes Dec 2019 Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)